 iHerb | $ 67.50 |
Natural vitamin E, tocotrienols, chlorophyllin, saffron, lycopene, and carotenoids create varied antioxidant coverage. The ingredient concept is broad and includes several compounds not usually found together.
The 173 mg MacuGuard blend hides its individual doses, limiting a meaningful potency comparison. Vitamin K is supplied at 3,735 mcg, making medication compatibility much more important than with an ordinary multivitamin.
The packet format carries weak value compared with the softgel version of the same listed formula. It only makes sense for users who specifically prefer packets and have confirmed that the high vitamin K amount is suitable.
Natural vitamin E and sodium magnesium chlorophyllin are favorable, but the vitamin K form and blend composition are unclear. Several ingredients have useful amounts, though the hidden blend contents prevent a complete dose assessment.
.Named actives have stated totals, but individual ingredients inside proprietary blends lack amounts. The supplied label data does not include a complete inactive ingredient list.
.The aggregate satisfaction measure and review volume support a favorable first impression. Missing firsthand feedback leaves repeat complaints and real-world purpose fit uncertain.
.The costly packet format is difficult to justify given the same major disclosure gaps. Each serving provides weak value despite several useful active ingredients.
.
Vitamin K and vitamin E provide calcium-management and antioxidant support relevant to vascular health. The broader antioxidant blend may add support, but the product is a general health booster rather than a focused heart formula.
The vitamin K amount is substantial, yet its forms are not separated and two proprietary blends obscure individual contributions. Vitamin K can oppose warfarin and other vitamin K antagonist medicines, making this high-dose formula unsuitable without coordinated anticoagulation management.
Vitamin E forms, tocotrienols, lycopene, saffron, and carotenoid ingredients provide broad antioxidant and tissue support. The design spans vascular, eye, and cellular aging pathways but is difficult to evaluate because several actives sit in proprietary blends.
The very large vitamin K total lacks subtype disclosure, preventing a reliable dose or form assessment. Vitamin K can counteract warfarin and related vitamin K antagonists, making clinician-guided consistency important for users of those medicines.
Sodium magnesium chlorophyllin provides a strong gut-level binding amount for certain ingested compounds. Its action is situational and does not directly support liver conjugation or antioxidant recycling.
The broader antioxidant and eye-health blend adds little metabolic-clearance depth and includes proprietary ingredients. The very high vitamin K content may interfere with warfarin and other vitamin K antagonist medicines.
Vitamin E and a large vitamin K amount provide some foundational antioxidant and calcium-regulation support. Several plant compounds broaden the formula, but key blends do not disclose their internal amounts.
The vitamin K subtype is not identified, so its suitability as K2 support cannot be confirmed. The very large vitamin K amount may oppose warfarin and related vitamin K antagonist medicines, making consistent clinician-guided use important for people taking them.
| Ingredient | Amount per serving |
|---|---|
Vitamin E (D-Alpha-Tocopherol) | 30.2 mg |
Vitamin K | 3735 mcg |
MacuGuard Proprietary Blend | 173 mg |
Chlorophyllin (Sodium Magnesium Chlorophyllin) | 100 mg |
Mixed Tocotrienols | 55 mg |
Saffron extract | 20 mg |
Lycopene Proprietary Blend (Lyc-O-Mato natural Tomato extract, micronized Lycopene) | 10 mg |
Supplies premium sodium magnesium chlorophyllin at a high-potency amount in a single softgel. Its source plant and elemental magnesium contribution are not disclosed, while the packet format is extremely costly for chlorophyllin alone. The very high vitamin K amount may disrupt warfarin or other vitamin K antagonist treatment.
The serving appears to include a softgel, but the very large vitamin K amount lacks any form or subtype disclosure. The absence of an MK-7 dose makes targeted K2 quality and efficacy impossible to judge. Its extreme cost is hard to support, and people taking warfarin should note that the large vitamin K amount may oppose the medicine's anticoagulant action.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
